Zura Bio
(NASDAQ) ZURA
Zura Bio Financials at a Glance
Market Cap
$356.24M
Revenue (TTM)
$0.00
Net Income (TTM)
-$75.43M
EPS (TTM)
-$1.22
P/E Ratio
-3.07
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Price
$3.75
Volume
1,765,869.167
Open
$3.63
Price
$3.75
Volume
1,765,869.167
Open
$3.63
Previous Close
$3.75
Daily Range
$3.52 - $3.80
52-Week Range
$1.00 - $7.44
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.63 (Low)
Price
$3.75
Volume
1,765,869.167
Open
$3.63
Previous Close
$3.75
Daily Range
$3.52 - $3.80
52-Week Range
$1.00 - $7.44
Estimated Earnings Date
Aug 13, 2026
ZURA News
ZURA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zura Bio
Industry
Biotechnology
Sector
Health CareEmployees
40
CEO
Sandeep C. Kulkarni, MD
Website
zurabio.comHeadquarters
San Diego, CA 92037, US
ZURA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-60%
Return on Capital
-38%
Return on Assets
-33%
Earnings Yield
-32.57%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$356.24M
Shares Outstanding
95.00M
Volume
1.77M
Avg. Volume
761.59K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$75.25M
EBITDA
-$68.60M
Operating Cash Flow
-$64.82M
Capital Expenditure
-$113.00K
Free Cash Flow
-$64.93M
Cash & ST Invst.
$109.41M
Total Debt
$0.00
Zura Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$16.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$356.24M
N/A
Market Cap/Employee
$11.87M
N/A
Employees
30
N/A
Net Income
-$24.22M
-38.9%
EBITDA
-$24.21M
-38.9%
Quarterly Fundamentals
Total Cash
$225.59M
+32.3%
Total Debt
$0.00
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-32.99%
N/A
Return on Invested Capital
-37.57%
N/A
Free Cash Flow
-$18.94M
-70.4%
Operating Cash Flow
-$18.92M
-71.0%
